via NetworkWire – Redfund Capital Corp (CNSX:LOAN.CN) (Frankfurt:O3X4) (OTC:PNNRF) backed Biolog Inc, a privately held company, and Cannabis Strategic Ventures, Inc. (OTC:NUGS), announced a partnership to develop water-soluble cannabis technologies to be used as ingredients for cannabis and phytocannabinoid rich-infused foods, beverages and consumer products. Under the agreement, Biolog will develop the new technologies in partnership with Cannabis Strategic Ventures and will jointly deploy marketing efforts to get the products to the marketplace.
Cannabinoids, including CBD, are hydrophobic substances, which are typically not soluble in water. Cannabis formulators have utilized various techniques to make CBD oils water compatible but continue to encounter many drawbacks to the existing techniques. The joint development effort between Biolog, Inc. and Cannabis Strategic Ventures will seek to push past these current limitations to develop a new set of function cannabinoids ingredients that can be easily added to foods, beverages, cosmetics and other consumer products in order to make cannabis more usable, thus significantly improving bioavailability and overall benefits to the human body.
Simon Yu, CEO, Cannabis Strategic Ventures comments, “We believe water-soluble cannabis technologies open new avenues of development for the development of cannabinoid-based products.” He added, “Over the past year we have reviewed several supposed water-soluble cannabinoids technologies but have passed on adoption due to technological limitations. The new product class that is in development with Biolog holds great potential and we are enthusiastically backing this developmental effort.”
Biolog believes its CBD-infusion technologies, CannaTab, CannaStix and others, which hold strong intellectual property protections, are increasingly relevant to the developing CBD edibles and beverages marketplaces. This new development effort in water-soluble CBD technologies is likely add a new product category to the Biolog product portfolio. Having quality partners such Cannabis Strategic Ventures and Redfund Capital significantly advance both the product development and IP portfolio agendas for Biolog, Inc. Biolog plans release of its initial product offerings over the coming weeks.
About Redfund Capital
Redfund intends to provide debt and equity funding in the mid-to-late stages of a target company’s development, or in technologies that are developed and validated by revenues. The present focus of the merchant bank is on medical cannabis, hemp and CBD-related, healthcare-related target companies.
About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing Cannabis consumer brands. The Company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publically traded on the U.S. Over the Counter Market with the stock symbol NUGS.
About Biolog, Inc.
Privately held Biolog, Inc., located in the San Francisco Bay area, has been organized to capitalize on the fast-growing market for cannabidiol (CBD) edibles and beverages. Biolog products solve many of the industry’s most pressing issues concerning cannabis edibles and beverages by offering precise dosing, micro-dosing, fast onset times, high bioavailability, taste masking and ease of use.
FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.
Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
For further information on Redfund Capital please contact
Meris Kott, CEO
For more information on Cannabis Strategic Ventures, Inc. please contact Arlene Guzman
Corporate Communications Contact:
New York, New York
<img src=”http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0Mzc1NTA=” alt=”” width=”1″ height=”1″/>